LLY

NYSE · Pharmaceuticals

Eli Lilly and Co.

S&P 500 Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$1,102.08

+3.51 (+0.32%)

As of Jun 22, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 79%

Hold 7 18%

Sell 1 3%

Price Target

Analyst Price Target +20.7% upside

Low Target $960.24

Average Target $1,330.33

High Target $1,470.76

Current Price $1,102.08

Current
$1,102.08

Target
$1,330.33

$960.24 $1,330.33 avg $1,470.76

Scenario Analysis

Bear Case

$960.24

-12.9%

Low target

Base Case

$1,330.33

+20.7%

Avg target

Bull Case

$1,470.76

+33.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$1,182.73

-6.8% from high

52-Week Low

$623.78

+76.7% from low

50-Day SMA

$1,008.19

+9.3% vs SMA

200-Day SMA

$964.27

+14.3% vs SMA

RSI (14)

46.8

Neutral

Target vs 52W High

$1,330.33

+12.5% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.7%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+29.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+37.9%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+35.2%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+219.0%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+176.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-32.3%